Migraine Functional Impact Questionnaire (MFIQ)

From GM-RKB
(Redirected from MFIQ)
Jump to navigation Jump to search

A Migraine Functional Impact Questionnaire (MFIQ) is a PRO assessment that is designed to capture the impact of migraine on physical, social, and emotional functioning within a 7-day time period.



References

2021

  1. 1.0 1.1 Stewart, W.F.; Lipton, R.B.; Kolodner, K.; Liberman, J.; Sawyer, J. "Reliability of the Migraine Disability Assessment Score in A Population-Based Sample of Headache Sufferers". Cephalalgia 1999, 19, 107–114.
  2. 2.0 2.1 Kosinski, M.R.; Bayliss, M.; Bjorner, J.; Ware, J.E., Jr.; Garber, W.; Batenhorst, A.; Cady, R.; Dahlöf, C.; Dowson, A.; Tepper, S. A six-item short-form survey for measuring headache impact: The HIT-6™. Qual. Life Res. 2003, 12, 963–974.
  3. 3.0 3.1 Martin, B.C.; Pathak, D.S.; Sharfman, M.I.; Adelman, J.U.; Taylor, F.R.; Kwong, W.J.; Jhingran, P. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache J. Head Face Pain 2000, 40, 204–216.
  4. D’Amico, D.; Raggi, A.; Grazzi, L.; Lambru, G. Disability, Quality of Life, and Socioeconomic Burden of Cluster Headache: A Critical Review of Current Evidence and Future Perspectives. Headache J. Head Face Pain 2020, 60, 809–818.
  5. Üstün, T.B.; Chatterji, S.; Kostanjsek, N.; Rehm, J.; Kennedy, C.; Epping-Jordan, J.; Saxena, S.; Von Korff, M.; Pull, C. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull. World Health Organ. 2010, 88, 815–823.
  6. Garin, O.; Ayuso, J.L.; Almansa, J.; Nieto, M.; Chatterji, S.; Vilagut, G.; Alonso, J.; Cieza, A.; Svestkova, O.; Burger, H.; et al. chronic diseases. Health Qual. Life Outcomes 2010, 8, 51.
  7. Ware, J.J. SF-36 Health Survey. Manual and Interpretation Guide; The Health Institute, New England Medical Center: Boston, MA, USA, 1993.
  8. Kawata, A.K.; Hareendran, A.; Shaffer, S.; Mannix, S.; Thach, A.; Desai, P.; Mikol, D.D.; Ortmeier, B.; Bayliss, M.; Buse, D.C. Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ). Headache J. Head Face Pain 2019, 59, 1253–1269.
  9. Kawata, A.K.; Hsieh, R.; Bender, R.; Shaffer, S.; Revicki, D.A.; Bayliss, M.; Buse, D.C.; Desai, P.; Sapra, S.; Ortmeier, B.; et al. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary. Headache J. Head Face Pain 2017, 57, 1385–1398.
  10. Hartmaier, S.L.; Santanello, N.C.; Epstein, R.S.; Silberstein, S.D. Development of a Brief 24-Hour Migraine-Specific Quality of Life Questionnaire. Headache J. Head Face Pain 1995, 35, 320–329.
  11. Santanello, N.C.; Hartmaier, S.L.; Epstein, R.S.; Silberstein, S.D. Validation of a New Quality of Life Questionnaire for Acute Migraine Headache. Headache J. Head Face Pain 1995, 35, 330–337.
  12. Raggi, A.; Covelli, V.; Guastafierro, E.; Leonardi, M.; Scaratti, C.; Grazzi, L.; Bartolini, M.; Viticchi, G.; Cevoli, S.; Pierangeli, G.; et al. Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: The HEADWORK questionnaire. J. Headache Pain 2018, 19, 85.

2019

2018

  1. Mannix S, Oko-Osi H, Gleeson S, et al. The migraine physical function impact diary: Content validity of a new instrument to evaluate the benefit of preventive migraine treatments. 5th European headache and migraine trust international congress, Glasgow, Scotland; 2016.
  2. Kawata AK, Hsieh R, Hareendran A, et al. Evaluating the measurement properties of a new instrument-the migraine physical function impact diary (MPFID) (P2. 156). Neurology. 2017;88:P2-156.
  3. Food Drug Administration (FDA). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. Fed Regist. 2009;74:65132-65133.